Addus HomeCare Corporation (NASDAQ:ADUS) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of Addus HomeCare Corporation (NASDAQ:ADUSGet Free Report) have received a consensus rating of “Moderate Buy” from the ten brokerages that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating, six have issued a buy rating and one has issued a strong buy rating on the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $131.00.

Several brokerages recently issued reports on ADUS. Barclays cut their target price on Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating on the stock in a research report on Friday, May 15th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research report on Wednesday, February 25th. KeyCorp reaffirmed an “overweight” rating on shares of Addus HomeCare in a research report on Wednesday, February 25th. Stephens cut their target price on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 25th. Finally, Citizens Jmp reaffirmed a “market outperform” rating and set a $142.00 target price on shares of Addus HomeCare in a research report on Monday, May 18th.

Get Our Latest Stock Analysis on ADUS

Addus HomeCare Stock Performance

NASDAQ ADUS opened at $93.28 on Wednesday. The company has a market cap of $1.74 billion, a price-to-earnings ratio of 17.24, a P/E/G ratio of 1.28 and a beta of 0.89. Addus HomeCare has a 52 week low of $87.95 and a 52 week high of $124.43. The business has a 50 day moving average price of $93.73 and a 200-day moving average price of $103.22. The company has a quick ratio of 1.83, a current ratio of 1.83 and a debt-to-equity ratio of 0.08.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last announced its earnings results on Monday, May 4th. The company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.52 by $0.10. The company had revenue of $363.50 million for the quarter, compared to analysts’ expectations of $366.41 million. Addus HomeCare had a return on equity of 9.80% and a net margin of 6.89%.Addus HomeCare’s quarterly revenue was up 7.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.42 earnings per share. As a group, equities analysts expect that Addus HomeCare will post 6.24 earnings per share for the current fiscal year.

Institutional Trading of Addus HomeCare

A number of hedge funds have recently bought and sold shares of ADUS. Royal Bank of Canada lifted its holdings in Addus HomeCare by 24.3% during the first quarter. Royal Bank of Canada now owns 6,899 shares of the company’s stock worth $682,000 after acquiring an additional 1,347 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Addus HomeCare by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company’s stock worth $1,026,000 after acquiring an additional 459 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Addus HomeCare by 6.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company’s stock worth $5,111,000 after acquiring an additional 2,952 shares during the period. Jane Street Group LLC lifted its holdings in Addus HomeCare by 387.6% during the first quarter. Jane Street Group LLC now owns 11,045 shares of the company’s stock worth $1,092,000 after acquiring an additional 8,780 shares during the period. Finally, Intech Investment Management LLC lifted its holdings in Addus HomeCare by 44.7% during the first quarter. Intech Investment Management LLC now owns 14,362 shares of the company’s stock worth $1,420,000 after acquiring an additional 4,439 shares during the period. 95.35% of the stock is currently owned by institutional investors.

About Addus HomeCare

(Get Free Report)

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

Featured Articles

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.